These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12855128)

  • 1. [Alfa-2b interferon-induced systemic lupus erythematosus in a patient with hepatitis C virus chronic infection].
    Sánchez Román J; Ocaña Medina C; García Hernández FJ; Mateos Romero L
    Rev Clin Esp; 2003 Aug; 203(8):406-7. PubMed ID: 12855128
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferon alpha-2b induced lupus erythematosus in a patient with chronic hepatitis C infection].
    Muñoz-Rodríguez FJ; Andreu Solsona V; Tricas Leris JM; Vilaseca Bellsolà J
    Rev Clin Esp; 2002 May; 202(5):299-300. PubMed ID: 12060551
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence.
    Lodato F; Tame MR; Colecchia A; Racchini C; Azzaroli F; D'Errico A; Casanova S; Pinna A; Roda E; Mazzella G
    World J Gastroenterol; 2006 Jul; 12(26):4253-5. PubMed ID: 16830387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-α induced lupus in a patient with chronic hepatitis C virus.
    Rizvi R; Hojjati M
    J Clin Rheumatol; 2011 Apr; 17(3):152-3. PubMed ID: 21441813
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C virus infection, interferon α and lupus; a curious combination.
    Auñón-Rubio P; Hernández-Martínez E; Sevillano-Prieto A; Morales-Ruiz E
    Nefrologia; 2014; 34(4):534-6. PubMed ID: 25036072
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature.
    Fukuyama S; Kajiwara E; Suzuki N; Miyazaki N; Sadoshima S; Onoyama K
    Am J Gastroenterol; 2000 Jan; 95(1):310-2. PubMed ID: 10638610
    [No Abstract]   [Full Text] [Related]  

  • 7. Lupus syndrome, hypothyroidism and bullous skin lesions after interferon alfa therapy for hepatitis C in a haemodialysis patient.
    Pouthier D; Theissen F; Humbel RL
    Nephrol Dial Transplant; 2002 Jan; 17(1):174. PubMed ID: 11773492
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C.
    Ho V; Mclean A; Terry S
    J Clin Rheumatol; 2008 Jun; 14(3):166-8. PubMed ID: 18525437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic lupus erythematosus syndrome induced by interferon therapy].
    Martínez Alfaro E; Mateos Rodríguez F; Blanch Sancho JJ; Tárraga Rodríguez I
    Med Clin (Barc); 2004 Oct; 123(15):597. PubMed ID: 15535949
    [No Abstract]   [Full Text] [Related]  

  • 10. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
    N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
    de Lédinghen V; Trimoulet P; Winnock M; Foucher J; Bourlière M; Desmorat H; Canva V; Capron D; Lévy S; Mion F; Mannant PR; Chêne G; Fleury H; Couzigou P; Bernard PH;
    J Hepatol; 2002 May; 36(5):672-80. PubMed ID: 11983451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
    McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
    N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary study on the efficacy and influencing factors of interferon for the treatment of genotype 1 chronic hepatitis C with different dosage forms.
    Ma P; Yang JM; Hou W; Song SD; Wang L; Lu W
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):601-5. PubMed ID: 23263720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin.
    Nasti G; Di Gennaro G; Tavio M; Cadorin L; Tedeschi RM; Talamini R; Carbone A; Tirelli U
    AIDS; 2001 Sep; 15(14):1783-7. PubMed ID: 11579239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of genotype 1b HCV-related chronic hepatitis: efficacy and toxicity of three different interferon alfa-2b/ribavirin combined regimens in naive patients.
    Scotto G; Fazio V; Palumbo E; Cibelli DC; Saracino A; Angarano G
    New Microbiol; 2005 Jan; 28(1):23-9. PubMed ID: 15782623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
    Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N
    Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891
    [No Abstract]   [Full Text] [Related]  

  • 17. Various sarcoid lesions in a patient induced by interferon therapy for chronic hepatitis C.
    Noguchi K; Enjoji M; Nakamuta M; Sugimoto R; Kotoh K; Nawata H
    J Clin Gastroenterol; 2002 Sep; 35(3):282-4. PubMed ID: 12192210
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C.
    Nelson DR; Rustgi V; Balan V; Sulkowski MS; Davis GL; Muir AJ; Lambiase LR; Dickson RC; Weisner RH; Fiscella M; Cronin PW; Pulkstenis E; McHutchison JG; Subramanian GM
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):212-8. PubMed ID: 19061971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised, double blind, placebo controlled trial of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment naïve patients with chronic hepatitis C.
    Thuluvath PJ; Maheshwari A; Mehdi J; Fairbanks KD; Wu LL; Gelrud LG; Ryan MJ; Anania FA; Lobis IF; Black M
    Gut; 2004 Jan; 53(1):130-5. PubMed ID: 14684587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyarthritis and anemia in a hemodialysis patient: systemic lupus erythematosus following treatment with interferon alpha.
    Touzot M; Touzot F; Galicier L; Ripault MP; Peraldi MN; Glotz D; Pillebout E
    Clin Nephrol; 2010 Apr; 73(4):318-20. PubMed ID: 20353741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.